Veterinary Medicine Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 47.97 Billion |
| Market Size (2029) | USD 69.12 Billion |
| CAGR (2024 - 2029) | 7.58 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Veterinary Medicine Market Analysis
The Veterinary Medicine Market size is estimated at USD 47.97 billion in 2024, and is expected to reach USD 69.12 billion by 2029, growing at a CAGR of 7.58% during the forecast period (2024-2029).
The impact of COVID-19 was observed in the livestock sector as well. The supply chain was disrupted, leading to difficulty in moving animal products such as meat, milk, and eggs to markets. Restrictions were implemented on the seasonal border crossing with ruminants. Therefore, lockdowns and limits had a significant negative impact on the industry under study. According to a new study published by the Nature Conservancy of Canada in April 2022, as the COVID-19 limitations started to loosen up, there was a rise in the demand for dog services on Canada's Prince Edward Island. The rise in pet ownership following the COVID-19 pandemic will have a favorable effect on the veterinary medicine industry throughout the course of the forecast period. Hence, even though the veterinary medicine market was significantly impacted by the COVID-19 pandemic during the early phase, currently, the market has gained traction, and it is expected to witness healthy growth during the forecast period.
The major factors responsible for the growth of the veterinary medicine market are the increasing burden of chronic diseases among animals, growing animal adoption, and the increase in drug preferences by pet and poultry farm owners, coupled with continued growth in the human population, leading to increased demand for meat and animal-based products. Currently, the global livestock population is also witnessing a surge. According to the United States Department of Agriculture (USDA), in February 2022, there are about 91.9 million cattle and calves and about 5.07 million sheep in the United States. This is expected to grow substantially in coming years.
Moreover, increasing research and development investments, high pet adoption rate, and growing consumption of meats and mandatory vaccination for the animals are anticipated to boost the demand for veterinary pharmaceuticals and vaccines for animals in the near future. The prevalence of zoonotic diseases and other chronic conditions in animals, such as Eastern equine encephalitis, a deadly infection affecting the brain, is increasingly contributing to the steady growth of the veterinary medicine business. It affects a wide range of creatures, including birds, amphibians, and reptiles. In animals, obesity is also an issue which is related to other diseases. For instance, according to an article published by frontiers in October 2022, obesity is one of the most common nutritional disease in dogs, and its prevalence has increased in recent decades. The article also stated that several countries have demonstrated a prevalence of obesity in dogs similar to that observed in humans. According to data from the United States Department of Agriculture (USDA) in May 2022, due to highly pathogenic avian influenza in backyards and commercial settings, approximately 37.96 million birds got infected.
The enormous bird population impacted by the disease and in need of effective diagnostic procedures contributes to the expansion of the market under investigation. Thus, the increasing burden of chronic diseases, coupled with the rising adoption of animals, is expected to boost market growth over the forecast period. Numerous recent development by key market players are another factor for the market growth. For instance, in September 2022, Zoetis announced that they have completed the acquisition of Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals. Furthermore, the major market players' ongoing product releases and developments for companion animals are fueling the market growth. For instance, in April 2021, Credelio Plus received a marketing authorization valid throughout the European Union. Thus, the above mentioned factors are expected to increase the market growth.
However, the high costs associated with animal healthcare and the lack of awareness about animal health in the emerging nations are expected to hinder the market growth.
Veterinary Medicine Market Trends
This section covers the major market trends shaping the Veterinary Medicine Market according to our research experts:
Dogs Segment is Expected to Hold A Significant Market Share Over the Forecast Period
- A significant rise in the adoption of pet animals, like dogs, the growing prevalence of various diseases in dogs, and the demand for dog vaccines are the major factors driving the growth of the veterinary medicine market. According to the annual report of the European Pet Food Industry Association (FEDIAF) 2022, dogs and cats are the major pets adopted in Europe, and in 2021, there were approximately 72,708,732 dogs in Europe. This trend is expected to rise further during the forecast period. Increasing initiatives by various governments in different regions improved animal healthcare and led to the increasing demand for dog medicine.
- Moreover, the prevalence of several diseases among dogs is a major contributor to the adoption of dog medicines. Cancer strikes dogs at a rate that is nearly identical to that of humans. According to an article published by ELIAS Animal Health in January 2022, cancer is one of the leading causes of death in dogs, and sometimes, the number is even higher than that in humans.
- Recent developments by the key market players are another factor in market growth. For instance, in July 2021, Elanco Animal Health Incorporated announced that the FDA granted full approval of tanovea for the treatment of lymphoma in dogs . Similarly, in August 2021, Virbac reported a breakthrough drug, STELFONTA (tigilanol tiglate injection), that was approved by the FDA as a non-surgical alternative for treating canine mast cell tumors in dogs. Thus, all the aforementioned factors are expected to boost segment growth over the forecast period of the study.
North America is Anticipated to Hold a Significant Market Share in the Veterinary Medicine Market Over the Forecast Period
- North America is expected to have a significant share of the veterinary medicine market during the forecast period of the study. Key contributing factors attributing to the growth are the increasing prevalence of zoonotic diseases, favorable reimbursement programs, and the rising expenditure on companion animals. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), around 70% of households in the United States own a pet, which equates to 90.5 million homes, including 45.3 million cats and 69 million dogs. The same source also reported that annual expenditure on routine visits for dogs accounted USD 242 for 2021, whereas it was USD 178 for cats.
- With the growing ownership of pets and livestock, US citizens have become more considerate of the health of these animals. According to the APPA, the expenditure on pets was USD 123.6 billion in the United States, and it is expected to rise, which may propel market growth. Thus, with increased awareness and expenditure on animal health, the market is expected to show significant growth over the forecast period. Furthermore, according to the data by the Canadian Animal Health Institute (CAHI) in September 2022, around 60% of Canadian households own at least one dog or cat. It also stated that the dog population increased to 7.9 million, and the cat population increased to 8.5 million in 2022.
- In addition, very few pet owners were aware of the causes of pet obesity, despite the fact that roughly 75% of pet owners were concerned about the health effects of obese pets. In addition, there is a huge presence of the key market players focused on the market developmental strategies in this region. For instance, in April 2022, Pharmgate Inc. received FDA approval for Pennitracin MD 50G for the prevention of mortality caused by necrotic enteritis associated with Clostridium perfringens in broiler and replacement chickens. In March 2022, Vetcare Oy received the FDA approval for Zenalpha, for use as a sedative and analgesic in dogs to facilitate clinical examination, clinical procedures, and minor surgical procedures. Thus, market propelling factors in the region are anticipated to offer exponential growth in the market studied. All these developments are further expected to fuel the market growth.
Veterinary Medicine Industry Overview
The Veterinary Medicine market is moderately fragmented in nature as it consists of several major players with marginal revenue differences. Among the leading animal health companies, Zoetis stands at the top in terms of revenue. Increasing consolidations of various organizations, like Boehringer Ingelheim Animal Health and Elanco, are expected to generate competitive rivalry among the key players in the future. Some major market players include Zoetis, Boehringer Ingelheim, Ceva, Merck, and Elanco, among others.
Veterinary Medicine Market Leaders
Zoetis
Merck & Co., Inc
Elanco
Ceva
Boehringer Ingelheim
*Disclaimer: Major Players sorted in no particular order
Veterinary Medicine Market News
- September 2022: The US FDA approved SpectoGard, the first generic spectinomycin sulfate injectable solution for the treatment of bovine respiratory diseases.
- September 2022: The US FDA approved Simplera Otic Solution, one of the first generic drug products that have a single-dose treatment with a 30-day duration of effect for otitis externa (outer ear infection) in dogs.
- June 2022: Vetmedin-CA1 (pimobendan) chewable tablets, the first medication intended for delaying the onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease, were approved by the US Food and Drug Administration (MMVD).
- June 2022: Agriculture Minister Narendra Singh Tomar launched India's first homegrown COVID-19 vaccine, Anocovax, for animals, developed by the Haryana-based ICAR-National Research Center on Equines (NRC). The vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant.
Veterinary Medicine Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Disease Conditions in Animals, Coupled with the Increasing Adoption of Animals
4.2.2 Increase in Drug Preferences by Pet and Poultry Farm Owners
4.2.3 Increased Demand for Meat and Animal-based Products in Agriculture and Human Healthcare
4.3 Market Restraints
4.3.1 High Costs Associated with Animal Healthcare
4.3.2 Lack of Awareness about Animal Health in the Emerging Nations
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Drugs
5.1.1.1 Anti-infectives
5.1.1.2 Anti-inflammatory
5.1.1.3 Parasiticides
5.1.1.4 Other Drugs
5.1.2 Vaccines
5.1.2.1 Inactive Vaccines
5.1.2.2 Attenuated Vaccines
5.1.2.3 Recombinant Vaccines
5.1.2.4 Other Vaccines
5.1.3 Medicated Feed Additives
5.1.3.1 Aminoacids
5.1.3.2 Antibiotics
5.1.3.3 Other Medicated Feed Additives
5.2 By Animal Type
5.2.1 Companion Animals
5.2.1.1 Dogs
5.2.1.2 Cats
5.2.1.3 Other Companion Animals
5.2.2 Livestock Animals
5.2.2.1 Cattle
5.2.2.2 Poultry
5.2.2.3 Swine
5.2.2.4 Sheep
5.2.2.5 Other Livestock Animals
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boehringer Ingelheim
6.1.2 Ceva Animal Health LLC
6.1.3 China Animal Husbandry Co. Ltd
6.1.4 Dechra Pharmaceuticals PLC
6.1.5 Elanco
6.1.6 Merck & Co. Inc.
6.1.7 Neogen Corporation
6.1.8 Phibro Animal Health Corporation
6.1.9 Sanofi SA
6.1.10 Vetoquinol SA
6.1.11 Virbac
6.1.12 Zoetis
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Veterinary Medicine Industry Segmentation
As per the scope of the report, veterinary drugs are used by veterinary professionals to treat diseases and injuries and help to promote growth in animals. These are majorly used to cure diseases and prevent the spread of infectious diseases among animals. These drugs indirectly benefit human healthcare by restricting the spread of infectious diseases from animals to humans. The market is segmented by Product Type (Drugs (Anti-infectives, Anti-inflammatory, Parasiticides, and Other Drugs), Vaccines (Inactive Vaccines, Attenuated Vaccines, Recombinant Vaccines, and Other Vaccines), Medicated Feed Additives (Aminoacids, Antibiotics, and Other Medicated Feed Additives), Animal Type (Companion Animals (Dogs, Cats, and Other Companion Animals), Livestock Animals (Cattle, Poultry, Swine, Sheep, and Other Livestock Animals), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product Type | ||||||
| ||||||
| ||||||
|
| By Animal Type | |||||||
| |||||||
|
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Veterinary Medicine Market Research FAQs
How big is the Veterinary Medicine Market?
The Veterinary Medicine Market size is expected to reach USD 47.97 billion in 2024 and grow at a CAGR of 7.58% to reach USD 69.12 billion by 2029.
What is the current Veterinary Medicine Market size?
In 2024, the Veterinary Medicine Market size is expected to reach USD 47.97 billion.
Who are the key players in Veterinary Medicine Market?
Zoetis , Merck & Co., Inc , Elanco , Ceva and Boehringer Ingelheim are the major companies operating in the Veterinary Medicine Market.
Which is the fastest growing region in Veterinary Medicine Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Veterinary Medicine Market?
In 2024, the North America accounts for the largest market share in Veterinary Medicine Market.
What years does this Veterinary Medicine Market cover, and what was the market size in 2023?
In 2023, the Veterinary Medicine Market size was estimated at USD 44.59 billion. The report covers the Veterinary Medicine Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Veterinary Medicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
What are the biggest challenges for veterinary drug manufacturers in emerging markets?
The biggest challenges for veterinary drug manufacturers in emerging markets are a) Counterfeit drugs b) Navigating complex regulations c) Limited access to research facilities
Veterinary Drugs Industry Report
The global veterinary medicine market is experiencing robust growth, spurred by advancements in pet medicine companies, a surge in animal protein demand, and a higher incidence of animal diseases. Noteworthy is the development of vaccines for Bovine Respiratory Diseases, underscoring innovations in veterinary care. Recovery from setbacks is fueled by increased pet adoptions and veterinary visits, despite macroeconomic challenges like inflation. Strategic mergers, acquisitions, and a focus on biosecurity are driving market expansion. The pharmaceutical segment leads in revenue, propelled by significant R&D investments and a rise in animal health expenditure. The production animals segment tops due to increased medicine uptake, while the injectable segment and e-commerce platforms are gaining traction, offering convenience and wider accessibility for veterinary medicines. Statistics for the Veterinary Healthcare market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Veterinary Healthcare analysis includes a market forecast outlook and historical overview. Get a sample of this industry analysis as a free report PDF download.
